Approval · Notice of Compliance 19267 · 2017
CINACALCET: Notice of Compliance 19267
Issued May 8, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19267
- Date
- May 8, 2017
- Company
- Jubilant Generics LimitedNoida, Uttar Pradesh, India
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- SENSIPAR (Amgen Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CINACALCET | 02463814 | Approved |
| CINACALCET | 02463822 | Approved |
| CINACALCET | 02463830 | Approved |
Medicinal ingredients
- CINACALCET HYDROCHLORIDE 30 MG per TAB
- CINACALCET HYDROCHLORIDE 60 MG per TAB
- CINACALCET HYDROCHLORIDE 90 MG per TAB